China Biotech Services Holdings Limited
China Biotech Services Holdings Limited (HKSE: 8037) is trading at HK$0.54, about ₹7 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 5.31% today. Indian residents can buy China Biotech Services from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.54
Today's high
HK$0.54
52 week low
HK$0.30
52 week high
HK$1.05
8037 opened at HK$0.54, closed previously at HK$0.57, and has traded between HK$0.30 and HK$1.05 over the past 52 weeks.
About
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
Key statistics
Avg. volume
459.69K
Market cap
HK$522.02M
P/E Ratio
-15.16
Price-to-sales ratio
5.72
Enterprise value
HK$930.06M
Free cash flow yield
0.00%
Debt-to-equity ratio
2.13
Return on equity
-15.60%
ROIC
-12.70%
Beta
-0.67
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
HK$73.50M
Earnings per share
-HK$0.07
Free cash flow
-HK$196.60M
Net profit margin
-37.84%
Gross margin
12.75%
EBITDA
-HK$59.65M
Revenue growth
4.25%
Similar securities
This is not an investment recommendation
How to buy China Biotech Services from India
Indian residents can buy China Biotech Services shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for China Biotech Services and place an order
Find China Biotech Services by name or by its ticker, 8037, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. China Biotech Services trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your China Biotech Services position in HKD and INR. China Biotech Services pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in China Biotech Services from India
Trading and taxes when buying China Biotech Services from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneChina Biotech Services does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy China Biotech Services stock?
Yes. China Biotech Services (8037) has been listed on the Hong Kong Stock Exchange since 2004, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one China Biotech Services share cost in rupees?
One China Biotech Services share is HK$0.54 — about ₹7 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the China Biotech Services price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying China Biotech Services from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of China Biotech Services?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on China Biotech Services shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the China Biotech Services price. Paasa issues a capital-gains statement for your return.
Does China Biotech Services pay a dividend?
No. China Biotech Services does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade China Biotech Services from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on China Biotech Services shares held from India?
Hong Kong has no estate duty.
Do I have to declare China Biotech Services shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your China Biotech Services holding, its cost and its closing value.
How do I sell China Biotech Services and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.